What to watch with COMT and blood sugar?

The link between COMT variants and blood sugar is not well established in current evidence. COMT (catechol-O-methyltransferase) degrades catecholamines like dopamine and adrenaline. The common Val158Met polymorphism (rs4680) alters enzyme activity: Met carriers have lower activity, potentially leading to higher catecholamine levels. Through stress pathways (cortisol, adrenaline), this could indirectly affect blood sugar regulation – for example, by promoting gluconeogenesis or insulin resistance under chronic stress. However, robust human studies directly linking COMT to fasting glucose, HbA1c, or diabetes risk are lacking. The evidence is mostly mechanistic. Blood sugar is multifactorial, driven by diet, exercise, sleep, stress, and many other genes (e.g., TCF7L2, GCK). A DNA test for COMT alone is not informative for blood sugar management. For optimization, focus on proven biomarkers like fasting glucose, HbA1c, and insulin, and consult a healthcare professional. Be cautious: genetic effects are small and context-dependent.